Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial 2021-02-10 19:12
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial 2021-02-10 19:00
Xi: China ready to cooperate with CEE countries on vaccines 2021-02-10 17:43
WAT Medical's Co-Founder receives UC Berkeley's 2021 Student Innovator Award 2021-02-09 22:00
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials 2021-02-09 21:53
Neurophth Closes RMB 400 Million Series B Financing 2021-02-09 21:44
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced 2021-02-09 21:00
Crisis and Opportunity Coexist: The Battle to Defend the Survival of Online Entertainment in the Pandemic (Part 2) - Interview with Color Star Technology Co., Ltd. (NASDAQ: CSCW) 2021-02-09 21:00
MDBriefCase Establishes World-Class Oncology Scientific Steering Committee 2021-02-09 19:00
Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China 2021-02-09 18:00
Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant 2021-02-09 11:18
Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products 2021-02-08 21:21
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 2021-02-08 21:00
CareCapital appoints Bindusaran as Executive Director 2021-02-08 18:14
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab 2021-02-06 06:27
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services 2021-02-05 19:00
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 18:41
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
1 298 299 300 301 302 871